Cargando…

Mortality rate of high cardiovascular risk patients with mild cognitive impairment

People with mild cognitive impairment (MCI) may be at higher risk of death than normal aging ones. On the other hand, patients with cardiovascular risk factors are also with higher risk of death. It may be logical to question then if the combination of MCI and cardio-vascular risk factors (in most c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaneva-Sirakova, Teodora, Traykov, Latchezar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279402/
https://www.ncbi.nlm.nih.gov/pubmed/35831445
http://dx.doi.org/10.1038/s41598-022-15823-1
_version_ 1784746389878603776
author Yaneva-Sirakova, Teodora
Traykov, Latchezar
author_facet Yaneva-Sirakova, Teodora
Traykov, Latchezar
author_sort Yaneva-Sirakova, Teodora
collection PubMed
description People with mild cognitive impairment (MCI) may be at higher risk of death than normal aging ones. On the other hand, patients with cardiovascular risk factors are also with higher risk of death. It may be logical to question then if the combination of MCI and cardio-vascular risk factors (in most cases arterial hypertension) can lead to higher mortality rate than expected both for high cardio-vascular risk patients and for the general population. This hypothesis is important in the light of effective early screening and prophylaxis. The general death rate of patients with very high-cardio-vascular-risk was compared in the subgroups of normal cognition and MCI. We used MMSE and MoCA (reassessment 6 months apart), Geriatric Depression scale and 4-point version of the scale for evaluating the performance in instrumental activities of daily living (4-IADL) in 249 patients. The patients also had laboratory testing, ambulatory blood pressure monitoring, ECG and echocardiography. The general mortality rate of this very high cardio-vascular risk group was assessed 8–10 years afterwards and also compared to the general national death rate published for the corresponding period from the National Social Security Institute of Bulgaria. We registered significantly higher general death rate in patients with MCI and very high cardio-vascular risk as compared to the group without MCI. The logistic regression analysis attributed approximately 14.6% of the mortality rate in this high-risk group to MCI. The major cardio-vascular risk factor was arterial hypertension—with 63.85% of the patients with home blood pressure values not in the target range at the initial cognitive screening. During the neuropsychological reevaluation 56.43% were with poor control despite the multidrug antihypertensive regimen. It is known that MCI is correlated with cardiovascular risk factors with the leading role of arterial hypertension. We found that the combination of MCI and arterial hypertension can lead to higher mortality rate than in the general aging population. This has important clinical implications for the everyday practice.
format Online
Article
Text
id pubmed-9279402
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-92794022022-07-14 Mortality rate of high cardiovascular risk patients with mild cognitive impairment Yaneva-Sirakova, Teodora Traykov, Latchezar Sci Rep Article People with mild cognitive impairment (MCI) may be at higher risk of death than normal aging ones. On the other hand, patients with cardiovascular risk factors are also with higher risk of death. It may be logical to question then if the combination of MCI and cardio-vascular risk factors (in most cases arterial hypertension) can lead to higher mortality rate than expected both for high cardio-vascular risk patients and for the general population. This hypothesis is important in the light of effective early screening and prophylaxis. The general death rate of patients with very high-cardio-vascular-risk was compared in the subgroups of normal cognition and MCI. We used MMSE and MoCA (reassessment 6 months apart), Geriatric Depression scale and 4-point version of the scale for evaluating the performance in instrumental activities of daily living (4-IADL) in 249 patients. The patients also had laboratory testing, ambulatory blood pressure monitoring, ECG and echocardiography. The general mortality rate of this very high cardio-vascular risk group was assessed 8–10 years afterwards and also compared to the general national death rate published for the corresponding period from the National Social Security Institute of Bulgaria. We registered significantly higher general death rate in patients with MCI and very high cardio-vascular risk as compared to the group without MCI. The logistic regression analysis attributed approximately 14.6% of the mortality rate in this high-risk group to MCI. The major cardio-vascular risk factor was arterial hypertension—with 63.85% of the patients with home blood pressure values not in the target range at the initial cognitive screening. During the neuropsychological reevaluation 56.43% were with poor control despite the multidrug antihypertensive regimen. It is known that MCI is correlated with cardiovascular risk factors with the leading role of arterial hypertension. We found that the combination of MCI and arterial hypertension can lead to higher mortality rate than in the general aging population. This has important clinical implications for the everyday practice. Nature Publishing Group UK 2022-07-13 /pmc/articles/PMC9279402/ /pubmed/35831445 http://dx.doi.org/10.1038/s41598-022-15823-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Yaneva-Sirakova, Teodora
Traykov, Latchezar
Mortality rate of high cardiovascular risk patients with mild cognitive impairment
title Mortality rate of high cardiovascular risk patients with mild cognitive impairment
title_full Mortality rate of high cardiovascular risk patients with mild cognitive impairment
title_fullStr Mortality rate of high cardiovascular risk patients with mild cognitive impairment
title_full_unstemmed Mortality rate of high cardiovascular risk patients with mild cognitive impairment
title_short Mortality rate of high cardiovascular risk patients with mild cognitive impairment
title_sort mortality rate of high cardiovascular risk patients with mild cognitive impairment
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279402/
https://www.ncbi.nlm.nih.gov/pubmed/35831445
http://dx.doi.org/10.1038/s41598-022-15823-1
work_keys_str_mv AT yanevasirakovateodora mortalityrateofhighcardiovascularriskpatientswithmildcognitiveimpairment
AT traykovlatchezar mortalityrateofhighcardiovascularriskpatientswithmildcognitiveimpairment